Related Experiment Video
Updated: Dec 11, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian
Shruthi Sriramkumar1, Timothy D Matthews1, Ahmed H Ghobashi2
1Cell, Molecular and Cancer Biology Graduate Program and Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana.
Abstract:
Platinum resistance is a common occurrence in high-grade serous ovarian cancer and a major cause of ovarian cancer deaths. Platinum agents form DNA cross-links, which activate nucleotide excision repair (NER), Fanconi anemia, and homologous recombination repair (HRR) pathways. Chromatin modifications occur in the vicinity of DNA damage and play an integral role in the DNA damage response (DDR). Chromatin modifiers, including polycomb repressive complex 1 (PRC1) members, and chromatin structure are frequently dysregulated in ovarian cancer and can potentially contribute to platinum resistance. However, the role of chromatin modifiers in the repair of platinum DNA damage in ovarian cancer is not well understood. We demonstrate that the PRC1 complex member RING1A mediates monoubiquitination of lysine 119 of phosphorylated H2AX (γH2AXub1) at sites of platinum DNA damage in ovarian cancer cells. After platinum treatment, our results reveal that NER and HRR both contribute to RING1A localization and γH2AX monoubiquitination. Importantly, replication protein A, involved in both NER and HRR, mediates RING1A localization to sites of damage. Furthermore, RING1A deficiency impairs the activation of the G2-M DNA damage checkpoint, reduces the ability of ovarian cancer cells to repair platinum DNA damage, and increases sensitivity to platinum. IMPLICATIONS: Elucidating the role of RING1A in the DDR to platinum agents will allow for the identification of therapeutic targets to improve the response of ovarian cancer to standard chemotherapy regimens.
Insights
Platinum resistance in ovarian cancer is linked to DNA repair. The study shows RING1A protein is crucial for repairing platinum DNA damage, suggesting it as a therapeutic target to improve chemotherapy response.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Platinum resistance is a major challenge in high-grade serous ovarian cancer treatment.
- DNA damage response (DDR) pathways, including nucleotide excision repair (NER) and homologous recombination repair (HRR), are activated by platinum agents.
- Chromatin modifiers, such as polycomb repressive complex 1 (PRC1), are dysregulated in ovarian cancer and may influence platinum resistance.
Purpose of the Study:
- To investigate the role of chromatin modifiers, specifically PRC1 members, in the DNA damage response to platinum agents in ovarian cancer.
- To elucidate the mechanism by which RING1A participates in repairing platinum-induced DNA damage.
Main Methods:
- Utilized ovarian cancer cell lines to study DNA damage response pathways.
- Investigated the localization and function of RING1A at sites of platinum DNA damage.
- Assessed the impact of RING1A deficiency on DNA repair, cell cycle checkpoints, and platinum sensitivity.
Main Results:
- RING1A mediates monoubiquitination of H2AX (γH2AXub1) at platinum DNA damage sites.
- NER and HRR pathways, along with replication protein A, are involved in RING1A recruitment and γH2AXub1 modification.
- RING1A deficiency compromises the G2-M DNA damage checkpoint, impairs DNA repair, and enhances platinum sensitivity in ovarian cancer cells.
Conclusions:
- RING1A plays a critical role in the DNA damage response to platinum chemotherapy in ovarian cancer.
- Targeting RING1A could be a strategy to overcome platinum resistance and improve treatment outcomes in ovarian cancer patients.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Anaphase Promoting Complex
The DNA Replication Fork
The Intrinsic Apoptotic Pathway

